Cumberland Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Cumberland Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Tennessee
- Headquarters city
- Nashville
- Headquarters state / province
- Tennessee
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- CPIX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001087294
- EIN
- 62-1765329
Board of directors
-
A. J. Kazimi · Director · Chairman and CEOSince 2023
-
Caroline Young · DirectorSince 2023
-
James Jones · DirectorSince 2023
-
Joey A. Jacobs · DirectorSince 2023
-
Joseph C. Galante · DirectorSince 2023
-
Kenneth Krogulski · DirectorSince 2023
-
Martin S. Brown Jr. · DirectorSince 2023
Chief executives
A. J. Kazimi
· Chairman and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 18, 2026 | Martin S. Brown Jr. Director | Grant or award | +1,800 | $2.80 | $5,040 |
| Mar 18, 2026 | Joseph C. Galante Director | Grant or award | +1,800 | $2.80 | $5,040 |
| Mar 18, 2026 | James Jones Director | Grant or award | +1,800 | $2.80 | $5,040 |
| Mar 18, 2026 | Kenneth Krogulski Director | Grant or award | +1,800 | $2.80 | $5,040 |
| Mar 18, 2026 | Caroline Young Director | Grant or award | +1,800 | $2.80 | $5,040 |
| Mar 18, 2026 | Kenneth Krogulski Director | Grant or award | +4,000 | $2.80 | $11,200 |
| Mar 16, 2026 | A. J. Kazimi Director, Officer (Chairman and CEO), 10% owner | Shares withheld for tax | −5,845 | $3.06 | $17,886 |
| Dec 31, 2025 | Caroline Young Director | Small acquisition | +5 | $3.91 | $20 |
| Dec 31, 2025 | James Jones Director | Small acquisition | +7 | $3.91 | $27 |
| Dec 31, 2025 | A. J. Kazimi Director, Officer (Chairman and CEO), 10% owner | Small acquisition | +7 | $3.91 | $27 |
| Dec 31, 2025 | Kenneth Krogulski Director | Small acquisition | +62 | $3.91 | $242 |
| Dec 30, 2025 | Caroline Young Director | Small acquisition | +2 | $3.94 | $8 |
| Dec 30, 2025 | James Jones Director | Small acquisition | +8 | $3.94 | $32 |
| Dec 30, 2025 | A. J. Kazimi Director, Officer (Chairman and CEO), 10% owner | Small acquisition | +8 | $3.94 | $32 |
| Dec 30, 2025 | Kenneth Krogulski Director | Small acquisition | +54 | $3.94 | $213 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Cumberland Pharmaceuticals Inc.
Who is the CEO of Cumberland Pharmaceuticals Inc.?
A. J. Kazimi is Cumberland Pharmaceuticals Inc.'s Chairman and CEO.
How many directors are on Cumberland Pharmaceuticals Inc.'s board?
Cumberland Pharmaceuticals Inc.'s board has 7 directors: A. J. Kazimi, Caroline Young, James Jones, Joey A. Jacobs, Joseph C. Galante, Kenneth Krogulski and Martin S. Brown Jr.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="cumberland-pharmaceuticals-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.